CHANSON INTERNATIONAL HOLD-A (CHSN)

KYG2104U1076 - Common Stock

4.99  -0.66 (-11.68%)

After market: 4.9 -0.09 (-1.8%)

Fundamental Rating

1

Overall CHSN gets a fundamental rating of 1 out of 10. We evaluated CHSN against 43 industry peers in the Consumer Staples Distribution & Retail industry. CHSN has a bad profitability rating. Also its financial health evaluation is rather negative. CHSN is valued expensive and it does not seem to be growing.



Quickly go to:

2

1. Profitability

1.1 Basic Checks

CHSN had negative earnings in the past year.
In the past year CHSN has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: CHSN reported negative net income in multiple years.
Of the past 5 years CHSN 4 years had a positive operating cash flow.

1.2 Ratios

CHSN has a worse Return On Assets (-0.59%) than 65.12% of its industry peers.
CHSN has a Return On Equity of -1.89%. This is in the lower half of the industry: CHSN underperforms 65.12% of its industry peers.
Industry RankSector Rank
ROA -0.59%
ROE -1.89%
ROIC N/A
ROA(3y)-0.86%
ROA(5y)0.42%
ROE(3y)-30.34%
ROE(5y)-11.26%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

In the last couple of years the Profit Margin of CHSN has declined.
The Gross Margin of CHSN (43.43%) is better than 90.70% of its industry peers.
In the last couple of years the Gross Margin of CHSN has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for CHSN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y-50.2%
GM growth 3Y-1.85%
GM growth 5Y-0.97%

More info and screens

2

2. Health

2.1 Basic Checks

CHSN does not have a ROIC to compare to the WACC, probably because it is not profitable.
CHSN has more shares outstanding than it did 1 year ago.
CHSN has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CHSN has a worse debt to assets ratio.

2.2 Solvency

An Altman-Z score of 2.58 indicates that CHSN is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.58, CHSN is doing worse than 62.79% of the companies in the same industry.
CHSN has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
CHSN has a better Debt to Equity ratio (0.26) than 67.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z 2.58
ROIC/WACCN/A
WACC7.46%

2.3 Liquidity

CHSN has a Current Ratio of 0.71. This is a bad value and indicates that CHSN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.71, CHSN is doing worse than 86.05% of the companies in the same industry.
A Quick Ratio of 0.66 indicates that CHSN may have some problems paying its short term obligations.
CHSN has a Quick ratio (0.66) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 0.71
Quick Ratio 0.66

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 84.23% over the past year.
CHSN shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -45.41% yearly.
Looking at the last year, CHSN shows a very negative growth in Revenue. The Revenue has decreased by -27.62% in the last year.
CHSN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.60% yearly.
EPS 1Y (TTM)84.23%
EPS 3YN/A
EPS 5Y-45.41%
EPS Q2Q%-92.96%
Revenue 1Y (TTM)-27.62%
Revenue growth 3Y18.72%
Revenue growth 5Y7.6%
Sales Q2Q%-14.4%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CHSN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CHSN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHANSON INTERNATIONAL HOLD-A

NASDAQ:CHSN (12/23/2024, 8:00:00 PM)

After market: 4.9 -0.09 (-1.8%)

4.99

-0.66 (-11.68%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.05%
Inst Owner ChangeN/A
Ins Owners50.95%
Ins Owner ChangeN/A
Market Cap106.84M
AnalystsN/A
Price TargetN/A
Short Float %11.35%
Short Ratio0.74
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.68
P/FCF N/A
P/OCF N/A
P/B 8.86
P/tB 8.97
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.17
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS0.75
BVpS0.56
TBVpS0.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.59%
ROE -1.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.43%
FCFM N/A
ROA(3y)-0.86%
ROA(5y)0.42%
ROE(3y)-30.34%
ROE(5y)-11.26%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y-50.2%
GM growth 3Y-1.85%
GM growth 5Y-0.97%
F-Score3
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 92.16%
Cap/Sales 5.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.71
Quick Ratio 0.66
Altman-Z 2.58
F-Score3
WACC7.46%
ROIC/WACCN/A
Cap/Depr(3y)189.45%
Cap/Depr(5y)164.76%
Cap/Sales(3y)8.57%
Cap/Sales(5y)7.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.23%
EPS 3YN/A
EPS 5Y-45.41%
EPS Q2Q%-92.96%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-27.62%
Revenue growth 3Y18.72%
Revenue growth 5Y7.6%
Sales Q2Q%-14.4%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-167.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-530.92%
OCF growth 3YN/A
OCF growth 5YN/A